Status:
UNKNOWN
Type 2 Diabetes and the Effect of Probiotics
Lead Sponsor:
Rigshospitalet, Denmark
Collaborating Sponsors:
Royal Veterinary and Agricultural University, Denmark
Conditions:
Type 2 Diabetes
Healthy
Eligibility:
MALE
25-80 years
Phase:
NA
Brief Summary
Insulin-resistance in type 2 diabetes is associated with chronic inflammation. Anti-inflammatory actions might increase sensitivity to insulin. Since some probiotics have anti-inflammatory properties,...
Detailed Description
Numerous studies have shown an association between insulin-resistance in type 2 diabetes and chronic low-grade inflammation. Some probiotics have an anti-inflammatory properties. Ingestion of probioti...
Eligibility Criteria
Inclusion
- Healthy
- Type 2 diabetes
Exclusion
- Heart failure
- Lung disease
- Infections in the last two weeks before endotoxin injections.
- Treatment with antibiotics
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
End Date :
December 1 2007
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00413348
Start Date
November 1 2006
End Date
December 1 2007
Last Update
December 19 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center of Inflammation and metabolism 7641 and Intensive Care Unit 4131, Rigshospitalet
Copenhagen, Denmark, DK-2100